Cost cutting: substandard care

Area of Science:

• Medical Ethics
• Health Economics
• Patient Advocacy

Background:

• A patient with a heart arrhythmia is undergoing successful medication treatment.
• The patient transitions to a Health Maintenance Organization (HMO) under a new physician.
• The new physician considers changing the patient's medication for cost-saving purposes.

Purpose of the Study:

• To argue against altering a patient's medication regimen for financial benefit without patient consultation.
• To explore the ethical implications of third-party influence on medical decisions.
• To advocate for the primacy of patient welfare in healthcare.

Main Methods:

• Ethical argumentation based on principles of medical ethics.
• Analysis of the doctor-patient relationship models.
• Discussion of potential negative social repercussions of cost-driven treatment changes.

Main Results:

• Changing medication solely for HMO cost reduction is ethically unsound.
• Patient autonomy and informed consent are paramount.
• Prioritizing patient welfare over financial incentives is essential for ethical medical practice.

Conclusions:

• Medical decisions should prioritize patient well-being above all else.
• Doctors must not allow third-party financial interests to influence treatment plans.
• An informative and collaborative doctor-patient relationship is the optimal model for medication management.